TherapeuticsMD (TXMD) EPS (Weighted Average and Diluted) (2021 - 2026)
TherapeuticsMD (TXMD) reported EPS (Weighted Average and Diluted) of $0.01 for Q1 2026, up 116.67% on a YoY basis from $0.0 in Q1 2025, and up 116.67% quarter-over-quarter from -$0.06 in Q4 2025.
TherapeuticsMD (TXMD) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
TherapeuticsMD has reported EPS (Weighted Average and Diluted) for 6 years, with the latest figure at $0.01 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 116.67% year-over-year to $0.01; the trailing twelve-month figure through Dec 2025 stood at -$0.07 (up 63.16% YoY), and the FY2025 full-year result was -$0.06, up 68.42% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.01, up from -$0.06 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $5.45 in Q4 2022, with the low at -$2.08 in Q1 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.07 across 5 years, with a median of -$0.07 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) soared 209.44% — and 2025, when it slumped 400.0%.
- TherapeuticsMD's EPS (Weighted Average and Diluted) stood at $5.45 in 2022, then tumbled by 102.57% to -$0.14 in 2023, then surged by 114.29% to $0.02 in 2024, then tumbled by 400.0% to -$0.06 in 2025, then jumped by 116.67% to $0.01 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at $0.01 (Q1 2026), -$0.06 (Q4 2025), and $0.01 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | TherapeuticsMD | 21,527.64 | -8.40 Mn | - | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | -0.06 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | -0.06 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | -0.05 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.07 |
| Dec 31, 2023 | -0.14 |
| Sep 30, 2023 | -0.32 |
| Jun 30, 2023 | -0.24 |
| Mar 31, 2023 | -0.37 |
| Dec 31, 2022 | 5.45 |
| Sep 30, 2022 | -1.58 |
| Jun 30, 2022 | -1.70 |
| Mar 31, 2022 | -2.08 |
| Dec 31, 2021 | -4.98 |
| Sep 30, 2021 | -5.62 |
| Jun 30, 2021 | -5.41 |